RU2646483C2 - Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений - Google Patents

Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений Download PDF

Info

Publication number
RU2646483C2
RU2646483C2 RU2014144360A RU2014144360A RU2646483C2 RU 2646483 C2 RU2646483 C2 RU 2646483C2 RU 2014144360 A RU2014144360 A RU 2014144360A RU 2014144360 A RU2014144360 A RU 2014144360A RU 2646483 C2 RU2646483 C2 RU 2646483C2
Authority
RU
Russia
Prior art keywords
compound
isoxazoline
nhch
methyl
composition
Prior art date
Application number
RU2014144360A
Other languages
English (en)
Russian (ru)
Other versions
RU2014144360A (ru
Inventor
Кейт ФРИХОФ
Ники УОЛДРОН
Юрген ЛУТЦ
Фрэнк Гуэрино
Original Assignee
Интервет Интернэшнл Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49300034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2646483(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Интервет Интернэшнл Б.В. filed Critical Интервет Интернэшнл Б.В.
Publication of RU2014144360A publication Critical patent/RU2014144360A/ru
Application granted granted Critical
Publication of RU2646483C2 publication Critical patent/RU2646483C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Mechanical Engineering (AREA)
  • Botany (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
RU2014144360A 2012-04-04 2013-04-03 Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений RU2646483C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12163198.0 2012-04-04
EP12163198 2012-04-04
US201361782028P 2013-03-14 2013-03-14
US61/782,028 2013-03-14
PCT/EP2013/056992 WO2013150055A1 (en) 2012-04-04 2013-04-03 Solid oral pharmaceutical compositions for isoxazoline compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2018104704A Division RU2772279C2 (ru) 2012-04-04 2013-04-03 Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений

Publications (2)

Publication Number Publication Date
RU2014144360A RU2014144360A (ru) 2016-05-27
RU2646483C2 true RU2646483C2 (ru) 2018-03-05

Family

ID=49300034

Family Applications (3)

Application Number Title Priority Date Filing Date
RU2014144360A RU2646483C2 (ru) 2012-04-04 2013-04-03 Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений
RU2014144001A RU2632965C2 (ru) 2012-04-04 2013-04-03 Мягкие жевательные фармацевтические продукты
RU2017133665A RU2765231C2 (ru) 2012-04-04 2013-04-03 Мягкие жевательные фармацевтические продукты

Family Applications After (2)

Application Number Title Priority Date Filing Date
RU2014144001A RU2632965C2 (ru) 2012-04-04 2013-04-03 Мягкие жевательные фармацевтические продукты
RU2017133665A RU2765231C2 (ru) 2012-04-04 2013-04-03 Мягкие жевательные фармацевтические продукты

Country Status (14)

Country Link
US (15) US9770440B2 (OSRAM)
EP (2) EP2833867B2 (OSRAM)
JP (2) JP6088637B2 (OSRAM)
KR (1) KR102077874B1 (OSRAM)
CN (4) CN109010296A (OSRAM)
AU (7) AU2013245011B2 (OSRAM)
BR (3) BR112014024832B1 (OSRAM)
CA (2) CA2869242C (OSRAM)
ES (1) ES2633611T5 (OSRAM)
FI (1) FI2833866T4 (OSRAM)
NZ (1) NZ631100A (OSRAM)
RU (3) RU2646483C2 (OSRAM)
WO (2) WO2013150052A1 (OSRAM)
ZA (2) ZA201406968B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2847348C1 (ru) * 2024-04-27 2025-10-03 Общество С Ограниченной Ответственностью "Научно-Исследовательский Центр "Фарматол" Противопаразитарное средство для лечения и профилактики эктопаразитозов собак.

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201404595TA (en) 2012-02-06 2014-09-26 Merial Ltd Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
BR112014024832B1 (pt) 2012-04-04 2022-05-31 Intervet International B.V. Método para a preparação de uma composição farmacêutica veterinária mastigável macia, composição farmacêutica, e, uso da composição
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
ES2742815T3 (es) 2013-12-10 2020-02-17 Intervet Int Bv Uso antiparasitario de compuestos de isoxazolina
HUE063842T2 (hu) 2013-12-20 2024-02-28 Intervet Int Bv Izoxazolin vegyületek felhasználása baromfiban
WO2015091898A1 (en) 2013-12-20 2015-06-25 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
MX2017005721A (es) * 2014-11-03 2017-07-28 Zoetis Services Llc Composicion veterinaria masticable agradable al paladar.
PL3236960T3 (pl) 2014-12-22 2025-07-07 Intervet International B.V. Fluralaner do zastosowania w leczeniu demodekozy
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
KR20190091268A (ko) * 2016-10-31 2019-08-05 더 스크립스 리서치 인스티튜트 매개체 전파 질환의 전염을 예방하기 위한 방법 및 조성물
CA3049952A1 (en) 2017-07-26 2019-01-31 Tgx Soft Chew, Llc Starch-free soft chew for veterinary applications
AR113997A1 (es) 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
SMT202400523T1 (it) * 2018-09-05 2025-01-14 Zoetis Services Llc Formulazioni antiparassitarie appetibili
MX2021013429A (es) * 2019-05-03 2021-12-10 Intervet Int Bv Composiciones farmaceuticas inyectables y usos de las mismas.
BR112022000982A2 (pt) * 2019-07-22 2022-03-08 Intervet Int Bv Forma de dosagem veterinária mastigável macia
AU2020409532A1 (en) * 2019-12-16 2022-05-12 Intervet International B.V. Composition for lice control
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
CA3191671A1 (en) * 2020-09-04 2022-03-10 Elanco Us Inc. Palatable formulations
CN117412673A (zh) * 2021-03-11 2024-01-16 碗中动物健康公司 犬科动物口服饲料和在犬科动物中控制蚤侵袭的方法
CA3211576A1 (en) * 2021-03-11 2022-09-15 In The Bowl Animal Health, Inc. Oral canine feed and methods for controlling tick infestations in a canine
AU2022300356A1 (en) * 2021-06-25 2023-11-30 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling flea infestations in a feline
AU2022299287A1 (en) * 2021-06-25 2023-12-14 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling tick infestations in a feline
CN113476419A (zh) * 2021-08-17 2021-10-08 江苏恒丰强生物技术有限公司 一种宠物用氟雷拉纳咀嚼片及其制备方法
WO2023086578A1 (en) * 2021-11-11 2023-05-19 Nutramax Laboratories, Inc. Soft chew
WO2023198476A1 (en) 2022-04-15 2023-10-19 Krka, D.D., Novo Mesto Soft chewable veterinary dosage form
CN117122571A (zh) * 2022-05-20 2023-11-28 天津瑞普生物技术股份有限公司 一种抗寄生虫感染的口服药物制剂及其制备方法和应用
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
WO2024196861A2 (en) * 2023-03-17 2024-09-26 Bimini, Llc Gastrointestinal health supplements
PE20251232A1 (es) * 2023-12-21 2025-04-29 Agrovet Market S A Composicion oral en forma de gel bioadhesivo a base de isoxazolina
CN119174733B (zh) * 2024-11-22 2025-03-25 济南广盛源生物科技有限公司 一种氟雷拉纳咀嚼片及其制备方法和用途
CN120346171A (zh) * 2025-03-13 2025-07-22 湖南尚成生物科技有限公司 一种弗雷拉纳咀嚼片及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095156A2 (en) * 2006-02-13 2007-08-23 Mpex Pharmaceuticals, Inc. Taste masking of aerosolized fluoroquinolones
US20100279999A1 (en) * 2007-12-24 2010-11-04 Syngenta Crop Protection, Inc. Insecticidal compounds
US20110118212A1 (en) * 2008-07-09 2011-05-19 Karsten Koerber Pestcidal active mixtures comprising isoxazoline compounds I
US20110245239A1 (en) * 2008-12-19 2011-10-06 Steve Nanchen Organic compounds
RU2433123C2 (ru) * 2005-12-30 2011-11-10 Е.И.Дюпон Де Немур Энд Компани Изоксазолины для борьбы с беспозвоночными вредителями

Family Cites Families (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB819681A (en) * 1957-01-24 1959-09-09 Wellcome Found Improvements in and relating to quaternary ammonium compounds and the preparation thereof
US3486186A (en) 1967-05-08 1969-12-30 Hollymatic Corp Molding apparatus
US3887964A (en) 1972-01-24 1975-06-10 Formax Inc Food patty molding machine
US3952478A (en) 1974-10-10 1976-04-27 Formax, Inc. Vacuum sheet applicator
US4054967A (en) 1975-10-20 1977-10-25 Formax, Inc. Food patty molding machine
US4284652A (en) 1977-01-24 1981-08-18 The Quaker Oats Company Matrix, product therewith, and process
US4182003A (en) 1978-02-28 1980-01-08 Formax, Inc. Food patty molding machine
US4338702A (en) 1979-03-29 1982-07-13 Holly Harry H Apparatus for making a ground food patty
US4334339A (en) 1980-05-12 1982-06-15 Hollymatic Corporation Mold device with movable compression insert
US4356595A (en) 1980-11-07 1982-11-02 Formax, Inc. Method and apparatus for molding food patties
US4327076A (en) 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4343068A (en) 1981-01-19 1982-08-10 Holly James A Method and apparatus for unidirectional formation of a plug-formed patty with cleanout feature
US4372008A (en) 1981-04-23 1983-02-08 Formax, Inc. Food patty molding machine with multi-orifice fill passage and stripper plate
US4393085A (en) 1981-08-13 1983-07-12 General Foods Corporation Enzyme digestion for a dog food of improved palatability
IE53474B1 (en) 1981-09-17 1988-11-23 Warner Lambert Co A chewable comestible product and process for its production
CH657506A5 (de) 1981-12-10 1986-09-15 Hollymatic Ag Portioniermaschine zum fuellen von hohlraeumen mit verformbarem material und verwendung derselben.
US4535505A (en) 1982-11-23 1985-08-20 Holly Systems, Inc. Method and apparatus for forming a patty to accommodate tissue fiber flow
US4608731A (en) 1983-01-11 1986-09-02 Holly Systems, Inc. Food patty with improved void structure, shape, and strength and method and apparatus for forming said patty
US4609543A (en) 1983-11-14 1986-09-02 Nabisco Brands, Inc. Soft homogeneous antacid tablet
US4597135A (en) 1984-02-21 1986-07-01 Holly Systems, Inc. Food patty forming method and apparatus employing two or more agitator bars
DE3406497A1 (de) 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US4768941A (en) 1986-06-16 1988-09-06 Hollymatic Corporation Food patty and machine and method for making thereof
US4697308A (en) 1986-10-29 1987-10-06 Formax, Inc. Patty molding mechanism for whole fiber food product
DE3636882C1 (de) 1986-10-30 1988-05-19 Schreiber Berthold Vorrichtung zur feinblasigen Einleitung eines Gases in eine Fluessigkeit
US4714620A (en) 1986-12-12 1987-12-22 Warner-Lambert Company Soft, sugarless aerated confectionery composition
US4780931A (en) 1987-02-13 1988-11-01 Marlen Research Corporation Feeding device for patty forming machine
US4821376A (en) 1988-06-02 1989-04-18 Formax, Inc. Seal-off for food patty molding machine with multi-orifice fill passage and stripper plate
US4997671A (en) 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US4872241A (en) 1988-10-31 1989-10-10 Formax, Inc. Patty molding mechanism for fibrous food product
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5021025A (en) 1989-09-12 1991-06-04 Wagner Richard C Method and machine for making food patties
US4975039A (en) 1989-09-18 1990-12-04 Dare Gary L Food molding and portioning apparatus
US4996743A (en) 1990-01-29 1991-03-05 Formax, Inc. Mold plate drive linkage
US5022888A (en) 1990-05-03 1991-06-11 Formax, Inc. Co-forming apparatus for food patty molding machine
US5262167A (en) 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
US5380535A (en) 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
JP2575325B2 (ja) 1991-06-18 1997-01-22 サクマ製菓株式会社 キャンディ
US5439924A (en) 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
TW376319B (en) 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
JPH10501211A (ja) 1994-05-20 1998-02-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 飼育動物用のチュワブル・フルベンダゾール錠剤
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
GB9508443D0 (en) 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
AUPN290395A0 (en) 1995-05-10 1995-06-01 Virbac (Australia) Pty Limited Canine anthelmintic preparation
US5578336A (en) 1995-06-07 1996-11-26 Monte; Woodrow C. Confection carrier for vitamins, enzymes, phytochemicals and ailmentary vegetable compositions and method of making
SK74396A3 (en) 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
US5606889A (en) 1995-09-19 1997-03-04 G & H Technology, Inc. Reusable initiator for use in triggering high-load actuators
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5730650A (en) 1996-08-29 1998-03-24 Progressive Technology Of Wisconsin, Inc. Food patty molding machine
US5655436A (en) 1996-08-29 1997-08-12 Progressive Technology Of Manitowoc, Inc. Food patty molding machine
US6086940A (en) 1996-10-25 2000-07-11 T.F.H. Publications, Inc. High starch content dog chew
US6110521A (en) 1996-10-25 2000-08-29 T.F.H. Publications, Inc. Wheat and casein dog chew with modifiable texture
US6093427A (en) 1997-09-03 2000-07-25 T.F.H.Publications, Inc. Vegetable-based dog chew
US5827565A (en) 1996-10-25 1998-10-27 T.F.H. Publications, Inc. Process for making an edible dog chew
US5753255A (en) 1997-02-11 1998-05-19 Chavkin; Leonard Chewable molded tablet containing medicinally active substances
AU747549B2 (en) 1998-03-23 2002-05-16 General Mills Inc. Encapsulation of components into edible products
US6093441A (en) 1998-07-15 2000-07-25 Tfh Publications, Inc. Heat modifiable peanut dog chew
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6387381B2 (en) 1998-09-24 2002-05-14 Ez-Med Company Semi-moist oral delivery system
US6060078A (en) 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
AU1816900A (en) * 1998-11-12 2000-05-29 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
US6159516A (en) 1999-01-08 2000-12-12 Tfh Publication, Inc. Method of molding edible starch
GB9902073D0 (en) 1999-01-29 1999-03-24 Nestle Sa Chewy confectionery product
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
EP1103181A1 (de) * 1999-11-25 2001-05-30 Novartis AG Kombination der N-Phenyl-N'-Benzoyl Harnstoff Derivaten und Avermectin für Parasiten Kontrolle.
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
IT1317048B1 (it) 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
WO2002060255A2 (en) 2001-01-31 2002-08-08 Bayer Cropscience Gmbh Herbicide-safener combination based on isoxozoline carboxylate safeners
EP1247456A3 (en) 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
JP2005505280A (ja) 2001-10-05 2005-02-24 ルビコン サイエンティフィック エルエルシー 有効成分を含む動物用飼料および該飼料を用いる方法
US20060141009A1 (en) 2002-08-13 2006-06-29 Sebastien Huron Novel compositions and processes for delivering an additive
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
GB0219639D0 (en) 2002-08-22 2002-10-02 Prestwick Scient Capital Inc Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders
US20040234579A1 (en) 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
AU2008201605B2 (en) 2003-07-30 2010-04-29 Novartis Ag Palatable ductile chewable veterinary composition
US6987111B2 (en) 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005016356A1 (en) 2003-08-08 2005-02-24 The Hartz Mountain Corporation Improved anthelmintic formulations
UA79571C2 (en) * 2003-12-04 2007-06-25 Basf Ag Metod for the protection of seeds from soil pests comprising
AR047530A1 (es) 2004-02-04 2006-01-25 Novartis Ag Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-(4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil)-benzamida
CN1930136B (zh) 2004-03-05 2012-02-08 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物及有害生物防除剂
KR20070008686A (ko) 2004-04-07 2007-01-17 인터벳 인터내셔널 비.브이. 벤지미다졸, 아버멕틴 및 프라지콴텔의 효능성 조성물 및이의 사용 방법
JP2008504229A (ja) † 2004-04-09 2008-02-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 過剰体重および肥満症患者のための間欠的投薬レジメン
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
WO2006123247A2 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
CA2621228C (en) 2005-09-02 2014-05-27 Nissan Chemical Industries, Ltd. Isoxazoline-substituted benzamide compound and pesticide
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20090143410A1 (en) 2005-12-14 2009-06-04 Kanu Maganbhai Patel Isoxazolines for Controlling Invertebrate Pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
PL1997813T3 (pl) 2006-03-10 2010-10-29 Nissan Chemical Ind Ltd Podstawiony związek izoksazolinowy i środek zwalczający szkodniki
WO2007123855A2 (en) 2006-04-20 2007-11-01 E. I. Du Pont De Nemours And Company Pyrazolines for controlling invertebrate pests
TWI342532B (en) * 2006-07-10 2011-05-21 Himax Tech Inc Method for generating a gamma table
JP2008044880A (ja) 2006-08-15 2008-02-28 Bayer Cropscience Ag 殺虫性イソオキサゾリン類
AU2007293068C1 (en) 2006-09-07 2013-09-19 Boehringer Ingelheim Animal Health USA Inc. Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
CN101190223A (zh) * 2006-11-29 2008-06-04 天津市润拓生物技术有限公司 一种犬猫用双羟萘酸噻嘧啶咀嚼片
US20090281059A1 (en) 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
EP2151437A4 (en) 2007-03-07 2012-05-02 Nissan Chemical Ind Ltd ISOXAZOLINE SUBSTITUTED BENZAMIDE COMPOUND AND PEST CONTROL AGENT
JP2008260691A (ja) * 2007-04-10 2008-10-30 Bayer Cropscience Ag 殺虫性アリールイソオキサゾリン誘導体
RU2009141185A (ru) 2007-04-10 2011-05-20 Байер КропСайенс АГ (DE) Инсектицидные производные арилизоксазолина
AU2007352619B2 (en) 2007-05-03 2013-07-18 Boehringer Ingelheim Animal Health USA Inc. Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
AU2008247327B2 (en) * 2007-05-07 2013-08-22 Jurox Pty Ltd Improved dosage form and process
EP2155699B9 (en) 2007-05-15 2016-09-14 Merial, Inc. Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
US20080293645A1 (en) * 2007-05-25 2008-11-27 Schneider Lawrence F Antiparasitic combination and method for treating domestic animals
BRPI0809770B8 (pt) 2007-06-13 2022-12-06 Du Pont Composto e composição para controlar uma praga de invertebrados
TWI430995B (zh) * 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2957284T3 (en) * 2007-06-27 2018-02-05 Du Pont PROCEDURE TO CHECK ANIMALS FOR ANIMALS
US8053452B2 (en) 2007-06-29 2011-11-08 Nissan Chemical Industries, Ltd. Substituted isoxazoline or enone oxime compound, and pest control agent
ITCL20070039A1 (it) 2007-07-10 2009-01-11 Michele Neri Bombolo a pressione costante con tubo estrusore a proboscide e valvola dosatrice, agganciato ad una struttura su cui scorre, azionato da una fonte di pressione controllata, utilizzabile in particolare per la estrusione-lavorazione di tutte le paste:
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
CN101801940B (zh) 2007-09-10 2013-04-10 日产化学工业株式会社 取代异*唑啉化合物和有害生物防除剂
PL2200588T3 (pl) 2007-09-25 2019-09-30 Solubest Ltd. Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania
KR20100075996A (ko) 2007-10-03 2010-07-05 이 아이 듀폰 디 네모아 앤드 캄파니 무척추 해충의 방제를 위한 나프탈렌 이속사졸린 화합물
BRPI0915818A2 (pt) * 2008-07-09 2015-08-04 Basf Se Mistura pesticida, composição pesticida, método para controlar fungos nocivos fitopatogênicos, para proteger plantas de fungos nocivos fitopatogênicos, para controlar insetos, aracnídeos ou nematódeos, para proteger plantas do ataque ou infestação por insetos, acarídeos ou nematódeos, e para a proteção de semente, semente, e, uso de uma mistura.
KR101963426B1 (ko) 2008-07-09 2019-03-28 닛산 가가쿠 가부시키가이샤 이속사졸린 치환 안식향산 아미드 화합물의 제조 방법
JP2010026724A (ja) * 2008-07-17 2010-02-04 Fujitsu Ltd Ｗｅｂページ提供装置、ｗｅｂページのランキング連動方法及びそのプログラム
AU2009289711A1 (en) 2008-09-04 2010-03-11 Syngenta Limited Insecticidal compounds
US9820977B2 (en) 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
AR074024A1 (es) 2008-11-14 2010-12-15 Merial Ltd Compuesto de arilazol-2-il-cianoetilamino enantiomericamente enriquecidos, composicion plaguicida y su uso para prevenir la infeccion parasitaria
KR101660068B1 (ko) 2008-11-19 2016-09-26 메리얼 인코포레이티드 기생충 감염 치료를 위한 1-아릴피라졸 단독 또는 포름아미딘과의 조합을 포함하는 조성물
TWI457347B (zh) 2008-12-04 2014-10-21 Merial Ltd 二聚合的阿佛菌素（ａｖｅｒｍｅｃｔｉｎ）及密倍脈心（ｍｉｌｂｅｍｙｃｉｎ）衍生物
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
CA2747986A1 (en) * 2008-12-23 2010-07-01 Basf Se Substituted amidine compounds for combating animal pests
US20110288089A1 (en) 2009-01-22 2011-11-24 Syngenta Crop Protection Llc Insecticidal compounds
JP2012522750A (ja) 2009-04-01 2012-09-27 ビーエーエスエフ ソシエタス・ヨーロピア 無脊椎動物害虫を駆除するためのイソキサゾリン化合物
AU2010100349B4 (en) * 2009-04-15 2012-03-29 Jurox Pty Ltd Anthelmintic formulation
US9040583B2 (en) 2009-07-22 2015-05-26 Temple University-Of The Commonwealth System Of Higher Education Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)
TWI487486B (zh) * 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物
RS58691B1 (sr) 2009-12-17 2019-06-28 Merial Inc Antiparazitske kompozicije dihidroazola
CN102762543B (zh) 2010-02-01 2016-03-09 巴斯夫欧洲公司 用于防除动物害虫的取代的酮型异*唑啉化合物和衍生物
KR20130010469A (ko) 2010-02-25 2013-01-28 신젠타 리미티드 이속사졸린 유도체를 포함하는 살충제 혼합물 및 살곤충 또는 살선충 생물학적 제제
WO2011124998A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
CN101919857B (zh) † 2010-05-05 2012-05-30 四川宝盛康药业有限公司 一种复方阿苯达唑咀嚼片及其应用和制备方法
MX2012013758A (es) 2010-05-27 2013-01-24 Du Pont Forma cristalina de 4-[5-[3-cloro-5-trifluorometil)fenil]-4,5-dihi dro-5-(trifluorometil)-3-isoxazolil]-n-[2-oxo-2-[(2,2,2-trifluoro etil)amino]etil]-1-naftalenocarboxamida.
BR112012031093A8 (pt) 2010-06-09 2017-10-10 Syngenta Participations Ag Misturas de pesticidas incluindo derivados da isoxazolina
EP2579723A2 (en) 2010-06-09 2013-04-17 Syngenta Participations AG Pesticidal mixtures comprising isoxazoline derivatives
AR081844A1 (es) 2010-06-09 2012-10-24 Syngenta Participations Ag Mezclas pesticidas incluyendo derivados isoxazolina
UY33403A (es) 2010-06-17 2011-12-30 Novartis Ag Compuestos orgánicos con novedosas isoxazolinas, sus n-óxidos, s-óxidos y sales
DK178277B1 (da) 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
CA2804147A1 (en) 2010-06-30 2012-01-05 Upsher-Smith Laboratories, Inc. Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid
WO2012007426A1 (en) 2010-07-13 2012-01-19 Basf Se Azoline substituted isoxazoline benzamide compounds for combating animal pests
JP2012046486A (ja) * 2010-07-30 2012-03-08 Sumitomo Chemical Co Ltd 動物外部寄生虫防除剤
PH12013500164A1 (en) 2010-08-05 2015-07-08 Zoetis Services Llc Isoxazoline derivatives as antiparasitic agents
WO2012038851A1 (en) 2010-09-24 2012-03-29 Pfizer Inc. Isoxazoline oximes as antiparasitic agents
CA2814082A1 (en) 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Non-starch based soft chewables
US9173870B2 (en) * 2010-12-27 2015-11-03 Intervet Inc. Topical localized isoxazoline formulation
PH12018501647A1 (en) 2011-09-12 2019-02-27 Merial Inc Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
BR112014012942A2 (pt) * 2011-11-29 2017-06-13 Novartis Ag uso de derivados de aril para controle de ectoparasitas
SG11201404595TA (en) * 2012-02-06 2014-09-26 Merial Ltd Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
BR112014024832B1 (pt) * 2012-04-04 2022-05-31 Intervet International B.V. Método para a preparação de uma composição farmacêutica veterinária mastigável macia, composição farmacêutica, e, uso da composição
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2433123C2 (ru) * 2005-12-30 2011-11-10 Е.И.Дюпон Де Немур Энд Компани Изоксазолины для борьбы с беспозвоночными вредителями
WO2007095156A2 (en) * 2006-02-13 2007-08-23 Mpex Pharmaceuticals, Inc. Taste masking of aerosolized fluoroquinolones
US20100279999A1 (en) * 2007-12-24 2010-11-04 Syngenta Crop Protection, Inc. Insecticidal compounds
US20110118212A1 (en) * 2008-07-09 2011-05-19 Karsten Koerber Pestcidal active mixtures comprising isoxazoline compounds I
US20110245239A1 (en) * 2008-12-19 2011-10-06 Steve Nanchen Organic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2847348C1 (ru) * 2024-04-27 2025-10-03 Общество С Ограниченной Ответственностью "Научно-Исследовательский Центр "Фарматол" Противопаразитарное средство для лечения и профилактики эктопаразитозов собак.

Also Published As

Publication number Publication date
BR122022008957B1 (pt) 2023-02-07
EP2833866B2 (en) 2024-11-27
US20190117565A1 (en) 2019-04-25
US9770440B2 (en) 2017-09-26
AU2013245011B2 (en) 2017-11-23
US20170290766A1 (en) 2017-10-12
US20220142984A1 (en) 2022-05-12
JP6088637B2 (ja) 2017-03-01
ES2633611T5 (es) 2023-09-26
EP2833867B2 (en) 2023-05-10
EP2833866A1 (en) 2015-02-11
RU2765231C2 (ru) 2022-01-26
CN108685894A (zh) 2018-10-23
AU2013245008B2 (en) 2017-03-30
US12396945B2 (en) 2025-08-26
NZ631100A (en) 2016-06-24
US20170172986A1 (en) 2017-06-22
ZA201406968B (en) 2015-06-24
WO2013150055A1 (en) 2013-10-10
US11285101B2 (en) 2022-03-29
AU2017204246A1 (en) 2017-07-13
KR20140141633A (ko) 2014-12-10
WO2013150052A1 (en) 2013-10-10
BR112014024832B1 (pt) 2022-05-31
RU2014144360A (ru) 2016-05-27
EP2833867A1 (en) 2015-02-11
US20150057239A1 (en) 2015-02-26
BR112014024833A2 (OSRAM) 2017-06-20
AU2019246812A1 (en) 2019-10-31
US20150057321A1 (en) 2015-02-26
AU2013245008A1 (en) 2014-10-16
US20190117564A1 (en) 2019-04-25
US11712416B2 (en) 2023-08-01
JP2015514103A (ja) 2015-05-18
AU2017268487A1 (en) 2017-12-14
BR112014024833A8 (pt) 2022-08-09
EP2833867B1 (en) 2017-05-17
US20190201332A1 (en) 2019-07-04
US20210177749A1 (en) 2021-06-17
CN104334159A (zh) 2015-02-04
CN108685894B (zh) 2022-04-26
RU2017133665A3 (OSRAM) 2021-01-25
CA2869242A1 (en) 2013-10-10
US20170266165A1 (en) 2017-09-21
US20200000718A1 (en) 2020-01-02
EP2833866B1 (en) 2018-11-21
JP2015512435A (ja) 2015-04-27
ZA201608614B (en) 2023-11-29
AU2021266292A1 (en) 2021-12-09
AU2019246812B2 (en) 2021-08-12
CN104203214A (zh) 2014-12-10
RU2014144001A (ru) 2016-05-27
JP6148724B2 (ja) 2017-06-14
BR112014024833B1 (pt) 2022-10-04
CA2868381C (en) 2020-07-07
FI2833866T4 (fi) 2025-01-31
US20230320981A1 (en) 2023-10-12
BR112014024832A2 (OSRAM) 2017-06-20
CA2868381A1 (en) 2013-10-10
CA2869242C (en) 2020-04-14
CN104203214B (zh) 2018-05-25
ES2633611T3 (es) 2017-09-22
AU2019213359A1 (en) 2019-08-29
RU2017133665A (ru) 2019-02-07
AU2013245011A1 (en) 2014-10-23
KR102077874B1 (ko) 2020-02-14
US20170100377A1 (en) 2017-04-13
AU2021266292B2 (en) 2025-02-06
US20170105972A1 (en) 2017-04-20
CN109010296A (zh) 2018-12-18
RU2632965C2 (ru) 2017-10-11
US11337917B2 (en) 2022-05-24
US20170172918A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
RU2646483C2 (ru) Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений
US10864195B2 (en) Topical localized isoxazoline formulation
RU2602189C2 (ru) Изоксазолиновый состав, содержащий гликофурол для наружного и местного применения
US20200390688A1 (en) Long-acting topical formulation and method of use thereof
RU2772279C2 (ru) Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений
US11903962B1 (en) Isoxazoline complexes and compositions thereof
US20240366572A1 (en) Isoxazoline complexes and compositions thereof
KR102193090B1 (ko) 국소 적용 이속사졸린 제제